Anoxia/reoxygenation-induced/JJ
tolerance/NN
with/IN
respect/NN
to/TO
polymorphonuclear/JJ
leukocyte/NN
adhesion/NN
to/TO
cultured/VBN
endothelial/JJ
cells/NNS
./.
=====
A/DT
nuclear/JJ
factor-kappaB-mediated/JJ
phenomenon/NN
./.

Exposing/VBG
human/JJ
umbilical/JJ
vein/NN
endothelial/JJ
cells/NNS
(/(
HUVECs/NNS
)/)
to/TO
anoxia/reoxygenation/NN
(/(
A/R/NN
)/)
results/VBZ
in/IN
an/DT
increase/NN
in/IN
polymorphonuclear/JJ
leukocyte/NN
(/(
PMN/NN
)/)
adhesion/NN
to/TO
HUVECs/NNS
./.
=====
This/DT
A/R-induced/JJ
hyperadhesion/NN
is/VBZ
completely/RB
prevented/VBN
by/IN
a/DT
previous/JJ
(/(
24/CD
hours/NNS
earlier/RBR
)/)
exposure/NN
of/IN
HUVECs/NNS
to/TO
A/R/NN
./.
=====
This/DT
phenomenon/NN
has/VBZ
been/VBN
termed/VBN
"/``
A/R/NN
tolerance/NN
./.
"/''
=====
Exposing/VBG
HUVECs/NNS
to/TO
A/R/NN
induces/VBZ
an/DT
increase/NN
in/IN
nuclear/JJ
factor/NN
kappaB/NN
(/(
NF-kappaB/NN
)/)
in/IN
HUVEC/NN
nuclei/NNS
within/IN
4/CD
hours/NNS
./.
=====
Interfering/VBG
with/IN
either/CC
NF-kappaB/NN
activation/NN
(/(
proteasome/NN
inhibitor/NN
)/)
or/CC
translocation/NN
(/(
double-stranded/JJ
oligonucleotides/NNS
containing/VBG
NF-kappaB/NN
binding/NN
sequence/NN
)/)
prevents/VBZ
the/DT
development/NN
of/IN
A/R/NN
tolerance/NN
(/(
ie/FW
,/,
the/DT
increase/NN
in/IN
A/R-induced/JJ
PMN/NN
adhesion/NN
to/TO
HUVECs/NNS
is/VBZ
the/DT
same/JJ
after/IN
the/DT
first/JJ
and/CC
second/JJ
A/R/NN
challenges/NNS
)/)
./.
=====
NO/NN
production/NN
by/IN
HUVECs/NNS
is/VBZ
increased/VBN
after/IN
the/DT
second/JJ
A/R/NN
challenge/NN
,/,
but/CC
not/RB
after/IN
the/DT
first/JJ
A/R/NN
challenge/NN
./.
=====
Inhibition/NN
of/IN
NO/DT
synthase/NN
(/(
NOS/NN
)/)
during/IN
the/DT
second/JJ
A/R/NN
challenge/NN
prevents/VBZ
the/DT
development/NN
of/IN
A/R/NN
tolerance/NN
with/IN
respect/NN
to/TO
PMN/NN
adhesion/NN
./.
=====
However/RB
,/,
while/IN
HUVECs/NNS
contained/VBD
endothelial/JJ
NOS/NN
protein/NN
,/,
no/DT
inducible/JJ
NOS/NN
was/VBD
detected/VBN
in/IN
either/CC
tolerant/JJ
or/CC
nontolerant/JJ
cells/NNS
./.
=====
Further/JJ
studies/NNS
indicated/VBD
that/IN
inhibition/NN
of/IN
GTP-cyclohydrolase/NN
I/CD
(/(
an/DT
enzyme/NN
involved/VBN
in/IN
de/FW
novo/FW
synthesis/NN
of/IN
an/DT
important/JJ
cofactor/NN
for/IN
NOS/NN
activity/NN
,/,
tetrahydrobiopterin/NN
)/)
prevented/VBD
the/DT
generation/NN
of/IN
NO/NN
in/IN
A/R-tolerant/JJ
cells/NNS
./.
=====
Extracellular/JJ
generation/NN
of/IN
NO/NN
(/(
NO/NN
donor/NN
)/)
did/VBD
not/RB
effect/VB
the/DT
hyperadhesion/NN
response/NN
induced/VBN
by/IN
the/DT
initial/JJ
A/R/NN
challenge/NN
./.
=====
A/R/NN
also/RB
induced/VBD
an/DT
oxidant/JJ
stress/NN
in/IN
naive/JJ
HUVECs/NNS
,/,
but/CC
not/RB
in/IN
A/R-tolerant/JJ
HUVECs/NNS
./.
=====
Inhibition/NN
of/IN
NOS/NN
during/IN
the/DT
second/JJ
A/R/NN
insult/NN
results/VBZ
in/IN
the/DT
generation/NN
of/IN
an/DT
oxidant/JJ
stress/NN
similar/JJ
to/TO
that/DT
observed/VBN
after/IN
the/DT
first/JJ
A/R/NN
challenge/NN
./.
=====
Taken/VBN
together/RB
,/,
the/DT
findings/NNS
of/IN
the/DT
present/JJ
study/NN
are/VBP
consistent/JJ
with/IN
a/DT
role/NN
for/IN
NF-kappaB/NN
in/IN
the/DT
development/NN
of/IN
A/R/NN
tolerance/NN
(/(
with/IN
respect/NN
to/TO
PMN/NN
adhesion/NN
)/)
,/,
perhaps/RB
by/IN
transcriptional/JJ
regulation/NN
of/IN
GTP-cyclohydrolase/NN
./.
=====
The/DT
increased/VBN
NO/NN
production/NN
during/IN
the/DT
second/JJ
A/R/NN
insult/NN
reduces/VBZ
PMN/NN
adhesion/NN
most/RBS
likely/RB
by/IN
reducing/VBG
the/DT
intracellular/JJ
oxidant/JJ
stress/NN
induced/VBN
by/IN
A/R/NN
./.